Page last updated: 2024-08-24

simendan and Left Heart Hypoplasia Syndrome

simendan has been researched along with Left Heart Hypoplasia Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Di Chiara, L; Di Molfetta, A; Haiberger, R; Iacobelli, R; Marinari, E; Ricci, Z; Toscano, A1
Di Chiara, L; Di Donato, RM; Garisto, C; Giorni, C; Morelli, S; Picardo, S; Ricci, Z; Vitale, V1

Trials

1 trial(s) available for simendan and Left Heart Hypoplasia Syndrome

ArticleYear
Initial experience with levosimendan infusion for preoperative management of hypoplastic left heart syndrome.
    Pediatric cardiology, 2010, Volume: 31, Issue:1

    Topics: Humans; Hydrazones; Hypoplastic Left Heart Syndrome; Infant, Newborn; Infusions, Intravenous; Pyridazines; Simendan; Vasodilator Agents

2010

Other Studies

1 other study(ies) available for simendan and Left Heart Hypoplasia Syndrome

ArticleYear
Effects of levosimendan on ventriculo-arterial coupling and cardiac efficiency in paediatric patients with single-ventricle physiology after surgical palliation: retrospective study.
    Interactive cardiovascular and thoracic surgery, 2020, 04-01, Volume: 30, Issue:4

    Topics: Cardiac Output, Low; Cardiotonic Agents; Echocardiography; Female; Heart Failure; Humans; Hypoplastic Left Heart Syndrome; Infant; Infant, Newborn; Male; Retrospective Studies; Simendan; Stroke Volume; Univentricular Heart; Ventricular Function, Left

2020